Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-14.43M
↓ 19% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-12.12M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-14.43M | -8.9% |
| 2024 | $-13.26M | -4.0% |
| 2023 | $-12.75M | +37.8% |
| 2022 | $-20.51M | -13.1% |
| 2021 | $-18.13M | -212.6% |
| 2020 | $-5.80M | -5.2% |
| 2019 | $-5.52M | +16.0% |
| 2018 | $-6.56M | - |